Neogenomics (NEO) Net Equity Issued and Repurchased (2010 - 2026)
Neogenomics' (NEO) quarterly Net Equity Issued and Repurchased came in at $2.1 million in Q2 2026, up 58.69% on a YoY basis from $1.3 million in Q2 2025, and up 718.34% quarter-over-quarter from -$338000.0 in Q1 2026.
Powered by 
Analysis
Neogenomics (NEO) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Net Equity Issued and Repurchased for 15 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Equity Issued and Repurchased rose 58.69% year-over-year to $2.1 million; the trailing twelve-month figure through Jun 2026 stood at $448000.0 (down 89.15% YoY), and the FY2025 full-year result was $962000.0, down 79.29% from the prior year.
- Net Equity Issued and Repurchased grew to $2.1 million in Q2 2026 per NEO's latest filing, from -$338000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $6.4 million in Q1 2022 and bottomed at -$1.7 million in Q3 2025.
- Historically, Net Equity Issued and Repurchased has averaged $1.4 million across 5 years, with a median of $1.3 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased soared 2013.98% in 2024, then slumped 247.41% in 2025.
- Over 5 years, Net Equity Issued and Repurchased stood at $1.9 million in 2022, then slumped by 31.28% to $1.3 million in 2023, then slumped by 46.08% to $687000.0 in 2024, then slumped by 37.26% to $431000.0 in 2025, then soared by 384.92% to $2.1 million in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $2.1 million, -$338000.0, and $431000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | - |
| 10 | Neogenomics | 2.55 Bn | 2.40 Bn | 91.88 Mn | 2.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.09 Mn |
| Mar 31, 2026 | -338,000.00 |
| Dec 31, 2025 | 431,000.00 |
| Sep 30, 2025 | -1.74 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 687,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 816,000.00 |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 3.09 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 6.40 Mn |
| Dec 31, 2021 | 2.97 Mn |
| Sep 30, 2021 | 4.07 Mn |
API Access
Neogenomics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();